PYC THERAPEUTICS LIM

PYC
End-of-day quote. End-of-day quote  - 01/19
0.15AUD -3.23%
Income Statement Evolution
Annual Income Statement Data
Fiscal Period: June 2015 2016 2017 2018 2019 2020
Net sales1 0,830,002,760,050,000,06
EBITDA1 -4,82-6,10-4,20-9,64-6,97-9,26
Operating profit (EBIT)1 -5,03-6,22-4,25-9,72-7,10-9,64
Operating Margin -607%-578 494%-154%-20 057%-2 840 740%-15 423%
Pre-Tax Profit (EBT)1 -4,96-6,05-4,18-9,60-6,98-9,48
Net income1 -2,99-3,98-1,95-7,43-4,08-6,82
Net margin -361%-369 765%-70,6%-15 340%-1 631 907%-10 916%
EPS2 0,000,000,000,000,000,00
Dividend per Share ------
Last update 08/30/201609/22/201709/21/201809/17/201909/14/202009/14/2020
1 AUD in Million
2 AUD
Finances - Leverage
Fiscal Period: June 2015 2016 2017 2018 2019 2020
Net Debt1 ------
Net Cash position1 1,487,079,943,156,1824,6
Leverage (Debt / EBITDA) 0,31x1,16x2,37x0,33x0,89x2,66x
Free Cash Flow1 -2,71-3,10-2,37-5,71-5,93-4,84
ROE (Net Profit / Equities) -128%-117%-26,6%-142%-103%-38,8%
Shareholders' equity1 2,343,407,345,253,9717,6
ROA (Net Profit / Asset) -99,7%-86,0%-30,2%-88,2%-87,7%-31,5%
Assets1 3,004,636,478,424,6521,7
Book Value Per Share2 0,000,000,000,000,000,01
Cash Flow per Share2 0,000,000,000,000,000,00
Capex1 0,060,030,000,210,460,11
Capex / Sales 7,78%2 489%0,16%435%183 016%170%
Last update 08/30/201609/22/201709/21/201809/17/201909/14/202009/14/2020
1 AUD in Million
2 AUD
Balance Sheet Analysis
Price Earning Ratio
EPS & Dividend